BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li GQ, Xu WZ, Wang JX, Deng WW, Li D, Gu HX. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells. World J Gastroenterol 2007; 13(16): 2324-2327 [PMID: 17511031 DOI: 10.3748/wjg.v13.i16.2324]
URL: https://www.wjgnet.com/2218-6247/full/v13/i16/2324.htm
Number Citing Articles
1
Bénédicte Ndeboko, Serge Thierry Omouessi, Brice Ongali, Augustin Mouinga-Ondémé. Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B VirusPharmaceuticals 2020; 13(12): 483 doi: 10.3390/ph13120483
2
Ruirui Xu, Pingping Hu, Yuwen Li, Anran Tian, Jun Li, Chuanlong Zhu. Advances in HBV infection and replication systems in vitroVirology Journal 2021; 18(1) doi: 10.1186/s12985-021-01580-6
3
Dvora Witt-Kehati, Maya Bitton Alaluf, Amir Shlomai. Advances and Challenges in Studying Hepatitis B Virus In VitroViruses 2016; 8(1): 21 doi: 10.3390/v8010021
4
Xiaojuan Chen, Yuanyu Qian, Fei Yan, Jian Tu, Xingxing Yang, Yaling Xing, Zhongbin Chen. 5′-Triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cellsEuropean Journal of Pharmacology 2013; 721(1-3): 86 doi: 10.1016/j.ejphar.2013.09.050
5
Jiradej Makjaroen, Poorichaya Somparn, Kenneth Hodge, Witthaya Poomipak, Nattiya Hirankarn, Trairak Pisitkun. Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected CellsMolecular & Cellular Proteomics 2018; 17(11): 2197 doi: 10.1074/mcp.RA118.000735
6
Laura Sneller, Christine Lin, Angie Price, Shyam Kottilil, Joel V. Chua. RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future ProspectsMicroorganisms 2024; 12(3): 599 doi: 10.3390/microorganisms12030599
7
Tianzhen Wang, Ran Zhao, Yiqi Wu, Dan Kong, Lei Zhang, Di Wu, Chao Li, Chong Zhang, Zuxi Yu, Xiaoming Jin. Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cellsVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-231
8
Constance N. Wose Kinge, Nimisha H. Bhoola, Anna Kramvis. In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and LimitationsViruses 2020; 12(3): 353 doi: 10.3390/v12030353
9
Jinghua Yu, Zengyan Wang, Peiyou Ren, Ting Zhong, Yue Wang, Fengmei Song, Jingwei Hou, Xiaoyan Yu, Shucheng Hua. Pseudolaric acid B inhibits the secretion of hepatitis B virusOncology Reports 2017; 37(1): 519 doi: 10.3892/or.2016.5254
10
Yong Chen, Guofeng Cheng, Ram I. Mahato. RNAi for Treating Hepatitis B Viral InfectionPharmaceutical Research 2008; 25(1): 72 doi: 10.1007/s11095-007-9504-0
11
Xiao-Min Xin, Gui-Qiu Li, Ying-Yu Jin, Min Zhuang, Di Li. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cellsWorld Journal of Gastroenterology 2008; 14(24): 3849-3854 doi: 10.3748/wjg.14.3849
12
Jin Shui PAN, Xiao Zhong WANG, Jian Lin REN. Long‐term RNA interference and its application to hepatitis B virusJournal of Digestive Diseases 2009; 10(3): 165 doi: 10.1111/j.1751-2980.2009.00381.x
13
Hadi Peeridogaheh, Zahra Meshkat, Shahram Habibzadeh, Mohsen Arzanlou, Jafar Mohammad Shahi, Sina Rostami, Sina Gerayli, Roghayeh Teimourpour. Current concepts on immunopathogenesis of hepatitis B virus infectionVirus Research 2018; 245: 29 doi: 10.1016/j.virusres.2017.12.007
14
Grace Sanghee Lee, Michael A. Purdy, Youkyung Choi. Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus InfectionsLife 2023; 13(7): 1527 doi: 10.3390/life13071527